Martin A Wasserman

Title: The Innovations of Martin A. Wasserman

Introduction

Martin A. Wasserman is a notable inventor based in Ambler, PA (US). He has made significant contributions to the field of medicine, particularly in the treatment of conditions related to thromboxane A.sub.2. His work has implications for various diseases, showcasing the importance of innovation in healthcare.

Latest Patents

Wasserman holds a patent for a method of antagonizing the effects of thromboxane. This patent, titled "Methods of antagonizing the effects of thromboxane A.sub.2 in the circulatory system of an animal," describes a process that involves administering a nontoxic effective amount of N,N'-bis[7-(3-chlorobenzeneaminosulfonyl)-1,2,3,4-tetrahydroisoquinolyl]di sulfonylimide or a pharmaceutical acceptable salt thereof. This invention is valuable in treating diseases where thromboxane A.sub.2 is a factor, such as thrombosis, endotoxic shock, and cardiac anaphylaxis. He has 1 patent to his name.

Career Highlights

Wasserman has had a distinguished career, working with Smithkline Beckman Corporation, where he has been able to apply his innovative ideas in a practical setting. His work has contributed to advancements in medical treatments and has had a positive impact on patient care.

Collaborations

Wasserman has collaborated with various professionals in his field, including his coworker Barry M. Weichman. These collaborations have likely enhanced the development and implementation of his innovative ideas.

Conclusion

Martin A. Wasserman's contributions to the field of medicine through his patent on thromboxane antagonism highlight the critical role of inventors in advancing healthcare solutions. His work exemplifies the impact of innovation on improving treatment options for serious medical conditions.